Re: Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting

Eur J Radiol. 2012 Oct;81(10):e967; author reply 2925-6. doi: 10.1016/j.ejrad.2012.04.015. Epub 2012 May 9.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Body Weight
  • Brain Neoplasms / diagnosis*
  • Contrast Media
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Meglumine*
  • Organometallic Compounds*
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Contrast Media
  • Organometallic Compounds
  • gadobutrol
  • Meglumine
  • gadoterate meglumine